Clinical Trials

Showing trials with last updates posted in 2026.

NCT07623187 | NOT_YET_RECRUITING | PHASE2/PHASE3
450 participants

A Study to Assess How Well the Study Medicine IPN60340 Works in Combination With Azacitidine and Venetoclax, Compared to Placebo in Combination With Azacitidine and Venetoclax, in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Cannot Receive Intensive Chemotherapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2026-11-01
Completion:
2031-05-31
Conditions
  • Acute Myeloid Leukaemia (AML)
  • Acute Myeloid Leukaemia
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT07620236 | NOT_YET_RECRUITING | NA
134 participants

The OK Daily Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2026-10-01
Completion:
2027-09-01
Conditions
  • Infant Vitamin K Status
  • Vitamin K Deficiency Bleeding
Interventions
  • OTHER
No Results Yet
NCT07613099 | RECRUITING | PHASE3
210 participants

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2026-09-09
Completion:
2031-05-26
Conditions
  • Allogeneic Stem Cell Transplantation
  • Lung Allograft Transplantation
  • Interstitial Lung Disease
  • Acute Lung Injury
  • Pulmonary Arterial Hypertension
  • Cardiovascular Diseases
Interventions
  • DRUG
  • DIAGNOSTIC_TEST
No Results Yet
NCT07600892 | ENROLLING_BY_INVITATION | NA
685 participants

Pain-at-Work Toolkit (Definitive Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2026-05-11
Completion:
2028-09-30
Conditions
  • Chronic Pain
  • Pain, Chronic
Interventions
  • OTHER
No Results Yet
NCT07574541 | NOT_YET_RECRUITING | PHASE2
52 participants

Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2026-09-09
Completion:
2027-06-15
Conditions
  • Adenocarcinoma
  • Prostate Cancer
  • Neoplasms
  • Carcinoma
  • Neoplasms, Glandular and Epithelial
  • Neoplasms by Histologic Type
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT07562152 | RECRUITING | PHASE3
510 participants

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2026-06-05
Completion:
2028-06-30
Conditions
  • Pancreatic Cancer
  • Pancreatic Cancer Metastatic
  • PDAC
  • PDAC - Pancreatic Ductal Adenocarcinoma
  • Pancreatic Ductal Adenocarcinoma
  • Pancreatic Adenocarcinoma Metastatic
  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • Pancreatic Adenocarcinoma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page